title: Weighing Alli's impact. Eating disorder patients might be tempted to abuse the first FDA-approved nonprescription diet pill.
authors.affiliation: Remuda Programs for Eating Disorders, USA. edward.cumella@remudaranch.com
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Cumella
authors.forename: Judy
authors.initials: J
authors.lastname: Hahn
authors.forename: Brenda K
authors.initials: BK
authors.lastname: Woods
mesh_terms: D019440:Anti-Obesity Agents; D000075202:Contraindications; D001068:Feeding and Eating Disorders; D006801:Humans; D007783:Lactones; D000077403:Orlistat; D014481:United States
chemical_list: D019440:Anti-Obesity Agents; D007783:Lactones; D000077403:Orlistat